The Digital Marketing Officer is an exciting new role that reflects the strategic importance of digital marketing to Cochrane ...

Sustained-release naltrexone may slightly increase illicit opioid use and serious adverse events compared to opioid agonists, with uncertain effects on retention and acceptability. It may reduce ...

Compared with placebo, PPIs may have no effect on the presence of global symptoms of dyspepsia and probably result in a slight reduction in global symptoms of dyspepsia scales. PPI probably reduces ...

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of exercise interventions for work-related complaints of the arm, neck or shoulder (CANS) ...

To explore the views and experiences of adolescents and youth who engaged with (i.e. were approached for participation) or participated in HIV research in low-and middle-income countries. To develop a ...

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions. Borys F, Sibrecht G, ...

Acupuncture may reduce pain assessed with different scales during the procedure, with little to no difference in any harms, when compared to no intervention. The evidence is very uncertain about the ...

The evidence does not currently support a clear benefit or harm for routine intravenous thrombolysis amongst people receiving endovascular thrombectomy. Amongst participants receiving endovascular ...

我们发现没有证据表明几种血管升压药的总死亡率有显著差异。与去甲肾上腺素相比，多巴胺会增加心律失常的风险，并可能增加死亡率。除此之外，关于六种血管升压素之间任何其他差异的 ...

このエビデンスがお役に立ちましたら、コクランへの寄付をご検討ください。私たちは、人々が医療やケアの意思決定をする際に役立つ、利用しやすいエビデンスを作成する慈善団体です。